Erratum to ‘Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database’ [European Journal of Cancer, Volume 125 (January 2020) Pages 153–163] (European Journal of Cancer (2020) 125 (153–163), (S0959804919308020), (10.1016/j.ejca.2019.10.030))

Nicolas Delanoy, Anne Claire Hardy-Bessard, Eleni Efstathiou, Sylvestre Le Moulec, Umberto Basso, Alison Birtle, Alastair Thomson, Michael Krainer, Aline Guillot, Ugo De Giorgi, Ali Hasbini, Gedske Daugaard, Amit Bahl, Simon Chowdhury, Orazio Caffo, Philippe Beuzeboc, Dominique Spaeth, Jean Christophe Eymard, Aude Fléchon, Jerome AlexandreCarole Helissey, Mohamed Butt, Frank Priou, Eric Lechevallier, Jean Laurent Deville, Marine Gross-Goupil, Rafael Morales, Antoine Thiery-Vuillemin, Tatiana Gavrikova, Philippe Barthélémy, Avishay Sella, Karim Fizazi, Jean Marc Ferrero, Brigitte Laguerre, Constance Thibault, Sophie Hans, Stéphane Oudard*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The publisher regrets that the following corrections were missed during the publication of this article. Figure 2 legend is missing from the published article and should appear as follows: Figure 2: Overall survival from initiation of each life-extending therapy in accordance with the type of progression in 661 patients with mCRPC. (A) OS from first life-extending therapy (LET) initiation (all arms combined), (B) OS from second LET initiation (all arms combined), and (C) OS from third LET initiation (all arms combined). Referring to Table 3, ‘Median OS (all arms combined) in months’, the 1st LET entry for the Clin-p column should appear as 30.7 [27.5; 32.9]. Referring to Figure 2A, median Clin-p should appear as 30.7 [27.5; 32.9]. The correct Figure is included here The publisher would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)290-291
Number of pages2
JournalEuropean Journal of Cancer
Volume137
DOIs
StatePublished - Sep 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'Erratum to ‘Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database’ [European Journal of Cancer, Volume 125 (January 2020) Pages 153–163] (European Journal of Cancer (2020) 125 (153–163), (S0959804919308020), (10.1016/j.ejca.2019.10.030))'. Together they form a unique fingerprint.

Cite this